Back to top
more

USANA Health Sciences (USNA)

(Delayed Data from NYSE)

$13.67 USD

13.67
185,637

-0.11 (-0.80%)

Updated Aug 26, 2026 04:00 PM ET

After-Market: $13.72 +0.05 (0.37%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 42% (103 out of 247)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Kinjel Shah headshot

5 Promising Price-to-Book Value Stocks to Buy in 2025

by Kinjel Shah

The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, USNA, CIO, TRTX and ITRI are some such stocks.

Zacks Equity Research

New Strong Buy Stocks for December 30th

by Zacks Equity Research

CCRD, APPN, USNA, TRDA and NRXP have been added to the Zacks Rank #1 (Strong Buy) List on December 30, 2024.

Zacks Equity Research

Best Value Stocks to Buy for December 30th

by Zacks Equity Research

USNA and BELFB made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 30, 2024.

Zacks Equity Research

USNA or UCBJY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

USNA vs. UCBJY: Which Stock Is the Better Value Option?

Zacks Equity Research

Is USANA Health Sciences (USNA) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

USANA Health Sciences (USNA) Q3 Earnings Surpass Estimates

by Zacks Equity Research

USANA Health (USNA) delivered earnings and revenue surprises of 14.29% and 3.95%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

PTC Therapeutics (PTCT) Surges 16.5%: Is This an Indication of Further Gains?

by Zacks Equity Research

PTC Therapeutics (PTCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

Profound Medical (PROF) Moves 5.1% Higher: Will This Strength Last?

by Zacks Equity Research

Profound Medical (PROF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

Xencor (XNCR) Surges 10.5%: Is This an Indication of Further Gains?

by Zacks Equity Research

Xencor (XNCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

USANA Health Sciences (USNA) Misses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

USANA Health (USNA) delivered earnings and revenue surprises of -16.92% and 2.64%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?